Biotech

All Articles

Kailera launches with $400M collection A, 4 Chinese being overweight medicines

.Kailera Therapies has launched right into the significantly crowded being overweight space along wi...

Metsera join Amneal to lock down GLP-1 supply

.Along with very early phase 1 data right now out in the wild, metabolic ailment clothing Metsera is...

Rivus articles information to support muscle-sparing obesity medicine claims

.Rivus Pharmaceuticals has actually revealed the data behind its phase 2 obesity win in cardiac arre...

BMS spends $110M to develop T-cell therapy treaty, aiding Main acquire opportunity to advance prioritized pipeline

.Bristol Myers Squibb is paying Excellent Medication $110 million beforehand to create reagents for ...

Generate gains yet another $1B-plus Major Pharma relationship

.Novartis has actually inked a package likely worth much more than $1 billion with Flagship-founded ...

Metsera GLP-1 data slice discloses 7.5% weight-loss at 36 days

.Lately debuted Metsera is actually unfolding some phase 1 data for its own GLP-1 receptor agonist, ...

Flagship wishes biotechs flock to Mirai to increase hereditary meds

.In the middle of the hereditary medications branches nationality, Front runner Pioneering is actual...

BioAge eyes $180M coming from IPO, exclusive positioning for obesity trials

.BioAge Labs is actually considering around $180 million in first profits coming from an IPO as well...

Merck's LAG-3 combination fails colorectal cancer period 3 research study

.An effort through Merck &amp Co. to open the microsatellite secure (MSS) metastatic colorectal canc...

Spanish VC shuts $200M life scientific researches fund

.Spain-based Asabys Allies has finalized a fund of 180 thousand europeans ($ 200 million), loan that...